Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Share News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Byotrol Gets US Approval For Sale Of Byotrol24 Sanitizer

Thu, 10th May 2018 14:16

LONDON (Alliance News) - Byotrol PLC said Thursday it has secured formal approval for sale of its anti-microbial product in all US states.

With the approval, the company said it is now able to sell the germ-kill surface sanitizer, Byotrol24, in US retail, on-line and to institutional sellers.

The anti-microbial technology company said the product had been previously approved by the US Environment Protection Agency in June 2017.

Byotrol secured the first order for Byotrol24 for sale via a "professional" re-seller on Amazon.com.

David Traynor, chief executive officer, said: "We are now, finally, ready to go in the US. We are very excited to complete the various regulatory processes and can now move confidently on to commercialisation."

"The order from the Amazon re-seller, whilst very small, is a key first step for us and we hope is the first in a series of positive announcements as we grow in the US."

Byotrol shares were lower 1.3% at 3.70 pence.

More News
1 Oct 2021 09:03

Byotrol sells surface spray formulation to Integrated Resources

Byotrol sells surface spray formulation to Integrated Resources

Read more
19 Aug 2021 14:14

IN BRIEF: Byotrol warns sanitiser sales set to drop after record year

IN BRIEF: Byotrol warns sanitiser sales set to drop after record year

Read more
12 Aug 2021 16:04

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Jun 2021 21:28

IN BRIEF: Byotrol backs new UK regulations on alcohol-free sanitisers

IN BRIEF: Byotrol backs new UK regulations on alcohol-free sanitisers

Read more
22 Apr 2021 18:33

TRADING UPDATES: Bank of Georgia wins Pipia case; MGC buys MediCaNL

TRADING UPDATES: Bank of Georgia wins Pipia case; MGC buys MediCaNL

Read more
22 Apr 2021 11:43

AIM WINNERS & LOSERS: Renalytix jumps on contract with US government

AIM WINNERS & LOSERS: Renalytix jumps on contract with US government

Read more
26 Feb 2021 17:57

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels

Read more
7 Dec 2020 14:10

Byotrol Reports Positive Interim Results On Pandemic-Driven Demand

Byotrol Reports Positive Interim Results On Pandemic-Driven Demand

Read more
13 Nov 2020 14:50

Byotrol Confident As Annual Results To Meet Expectations

Byotrol Confident As Annual Results To Meet Expectations

Read more
13 Nov 2020 08:35

Byotrol trading 'remains healthy', in line with FY expectations

(Sharecast News) - Infection prevention and control company Byotrol said on Friday that trading had remained at "healthy levels" across all business units and product sales.

Read more
6 Nov 2020 16:54

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
24 Sep 2020 14:51

IN BRIEF: Byotrol Swings To Annual Loss On Higher Expenses

IN BRIEF: Byotrol Swings To Annual Loss On Higher Expenses

Read more
7 Sep 2020 13:53

IN BRIEF: Byotrol Gets GBP350,000 Grant For Anti-Viral Uses Of Seaweed

IN BRIEF: Byotrol Gets GBP350,000 Grant For Anti-Viral Uses Of Seaweed

Read more
7 Sep 2020 09:15

Byotrol gets ?0.35m grant for seaweed research

(Sharecast News) - Specialist infection prevention company Byotrol has secured a "significant" £0.35m grant from Innovate UK, it announced on Monday, to further investigate the anti-viral properties of certain common forms of seaweed.

Read more
3 Aug 2020 18:22

UK TRADING UPDATE SUMMARY: Tiziana Offering to Raise GBP57 Million

UK TRADING UPDATE SUMMARY: Tiziana Offering to Raise GBP57 Million

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.